Need all Congresses? Press Enter for expanded federal results.

HB 4626

West Virginia - Session 2026RS

House of Delegates vetoed 2026-03-14
Bill Details

Title: Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine

Summary

Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine

Sponsor
Ryan Browning
Official Source Back to Bills
Actions Timeline
Date Event Detail
2026-01-21 Introduced Bill introduced
2026-03-14 Status vetoed
2026-03-14 Latest Action Vetoed
More Bills From This Sponsor
HB 5686
Relating to the timing of payments of annually required deposit into an eligible recipient’s Hope Scholarship account
enacted • House of Delegates
HB 4999
Relating to crimes against athletic officials
enacted • House of Delegates
HB 5437
Creating the Vape Safety Act
enacted • House of Delegates
HB 4869
Establish narrow, clearly bounded guaranteed-issue rights for Medicare Supplement policies in West Virginia.
enacted • House of Delegates
HB 5022
Relating to expanding the programs to be included in the annual capitation rate review.
enacted • House of Delegates
HB 5327
West Virginia ALS Care Services Act
enacted • House of Delegates